Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on December 1, 2005

Stroke. 2005
Published online before print December 1, 2005, doi: 10.1161/01.STR.0000195133.98378.4b
A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/1/231    most recent
01.STR.0000195133.98378.4bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Achrol, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Achrol, A. S.
Related Collections
Right arrow Acute Cerebral Hemorrhage
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

Submitted on August 2, 2005
Revised on August 29, 2005
Accepted on September 2, 2005

Tumor Necrosis Factor-{alpha}-238G>A Promoter Polymorphism Is Associated With Increased Risk of New Hemorrhage in the Natural Course of Patients With Brain Arteriovenous Malformations

Achal S. Achrol BS; Ludmila Pawlikowska PhD; Charles E. McCulloch PhD; K. Y. Trudy Poon MS; Connie Ha BS; Jonathan G. Zaroff MD; S. Claiborne Johnston MD, PhD; Chanhung Lee MD, PhD; Michael T. Lawton MD; Stephen Sidney MD, MS; Douglas A. Marchuk PhD; Pui-Yan Kwok MD, PhD; William L. Young MD*; for the UCSF BAVM Study Project

From the Departments of Anesthesia and Perioperative Care and Center for Cerebrovascular Research (A.S.A., K.Y.P., C.L., W.L.Y.), Cardiovascular Research Institute (L.P., C.H., P.Y.K.), Departments of Epidemiology and Biostatistics (C.E.M., S.C.J.), Neurology (S.C.J., W.L.Y.), Medicine (J.G.Z.), Neurological Surgery (M.T.L., W.L.Y.), University of California, San Francisco, California; Division of Research, Kaiser-Permanente Medical Care Program, Oakland, Calif (S.S.); and the Department of Genetics, Duke University Medical Center, Durham, NC (D.A.M.).

* To whom correspondence should be addressed. E-mail: ccr{at}anesthesia.ucsf.edu.

Background and Purpose--Identification of single-nucleotide polymorphisms (SNPs) associated with increased risk of new intracranial hemorrhage (ICH) after brain arteriovenous malformation (BAVM) diagnosis would facilitate risk stratification and identify potential targets for therapeutic intervention.

Methods--Patients with BAVM were longitudinally followed. Primary outcome was new ICH after diagnosis; censoring events were last follow-up or any BAVM treatment. We genotyped 4 promoter SNPs in 2 inflammatory cytokine genes: interleukin-6 (IL-6-174G>C; IL-6-572G>C) and tumor necrosis factor-{alpha} (TNF-{alpha}-238G>A; TNF-{alpha}-308G>A). Association of genotype with risk of new ICH was screened using {chi}2; SNPs associated with new ICH were further characterized using Cox proportional hazards.

Results--We genotyped 280 patients (50% female; 59% white, mean±SD age at diagnosis 37±17 years; 40% presenting with ICH). TNF-{alpha}-238G>A was associated with increased risk of new ICH after diagnosis ({chi}2; P=0.003). After adjusting for age, race/ethnicity, and clinical presentation, the risk of new ICH was increased for patients with TNF-{alpha}-238 AG genotype (hazard ratio, 4.01; P=0.015). No other SNP was found to be associated with new ICH.

Conclusion--A TNF-{alpha} SNP was associated with increased risk of new ICH in the natural course of BAVMs. The role of inflammatory cytokines in the pathogenesis of BAVM hemorrhage merits further study.


Key words: cerebral hemorrhage • genetics • vascular malformations




This article has been cited by other articles:


Home page
StrokeHome page
G. G. Leblanc, E. Golanov, I. A. Awad, W. L. Young, and Biology of Vascular Malformations of the Brain NIN
Biology of Vascular Malformations of the Brain
Stroke, December 1, 2009; 40(12): e694 - e702.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
S. Weinsheimer, H. Kim, L. Pawlikowska, Y. Chen, M. T. Lawton, S. Sidney, P.-Y. Kwok, C. E. McCulloch, and W. L. Young
EPHB4 Gene Polymorphisms and Risk of Intracranial Hemorrhage in Patients With Brain Arteriovenous Malformations
Circ Cardiovasc Genet, October 1, 2009; 2(5): 476 - 482.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Kim, L. Pawlikowska, Y. Chen, H. Su, G.-Y. Yang, and W. L. Young
Brain Arteriovenous Malformation Biology Relevant to Hemorrhage and Implication for Therapeutic Development
Stroke, March 1, 2009; 40(3_suppl_1): S95 - S97.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J van Beijnum, H B van der Worp, H M Schippers, O van Nieuwenhuizen, L J Kappelle, G J E Rinkel, J W B. van der Sprenkel, and C J M Klijn
Familial occurrence of brain arteriovenous malformations: a systematic review
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1213 - 1217.
[Abstract] [Full Text] [PDF]